“Giant” subcutaneous composite classic/spindle cell lipoma

Czech version

Authors: V. Bartoš ¹; M. Čanecká ²
Authors‘ workplace: Martinské bioptické, centrum, s. r. o., Martin, Slovenská republika ¹; Chirurgické oddelenie, Kysucká nemocnica, s poliklinikou, Čadca, Slovenská republika ²
Published in: Rozhl. Chir., 2025, roč. 104, č. 5, s. 199-204.
Category: Case Report
doi: https://doi.org/10.48095/ccrvch2025199

Overview

Introduction: Lipomas belong to the most common soft tissue tumors. If they reach at least 10 cm or weigh at least 1,000 g, they are referred to as giant lipomas. Such lesions can cause diagnostic quandaries at a biopsy examination.

Case report: The article describes a 58-year-old man who observed the progression of a subcutaneous tumor mass in the right side of the back for two years. It looked like a fibrolipoma on an ultrasound. Complete surgical extirpation was performed. Grossly, it was an encapsulated lobulated lipomatous tumor measuring 12 × 10 × 4 cm. It consisted of a composite classical and spindle cell lipoma. The spindle cell component required differentiation from an atypical lipomatous tumor, which is an oncological entity with a worse prognosis.

Conclusion: Subcutaneous lipomas over 10 cm are rare and represent a diagnostic challenge for both clinicians and pathologists. We tried to point out that lipomatous tumors of larger dimensions and especially those with a heterogeneous morphological appearance should urge the pathologist to think about a potential malignancy and require more complex differential-diagnostic approach.

Keywords:

atypical lipomatous tumor – giant lipoma – spindle cell lipoma

Sources

1. Kher C, Chakole S. Giant lipoma: a case report. Cureus 2024; 16(1): e53000. doi: 10.7759/cureus.53000.

2. Yildirim ANT, Zenginkinet T, Okay E et al. Clinical results of surgical treatment of giant lipomas: a single-center experience. Duzce Med J 2022; 24(2): 126–130. doi: 10.18678/dtfd.1068051.

3. Yee EJ, Stewart CL, Clay MR et al. Lipoma and its doppelganger: the atypical lipomatous tumor/well-differentiated liposarcoma. Surg Clin North Am 2022; 102(4): 637–656. doi: 10.1016/j.suc.2022.04.006.

4. Zoubková V, Třeška V, Rupert K. Madelungs disease – a case report. Rozhl Chir 2019; 98(6): 260–264.

5. WHO. Soft tissue and bone tumours. 2020 [online]. Dostupné z: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Soft-Tissue-And-Bone-Tumours-2020.

6. Zenginkinet T, Okay E, Celik A et al. Clinical results after surgical treatment of spindle cell lipomas. Duzce Med J 2021; 23(3): 258–262. doi: 10.18678/dtfd.954752.

7. Terzioglu A, Tuncali D, Yuksel A et al. Giant lipomas: a series of 12 consecutive cases and a giant liposarcoma of the thigh. Dermatol Surg 2004; 30(3): 463–467. doi: 10.1111/j.1524-4725.2004.30022.x.

8. Vagholkar K, Bhatnagar I, Vagholkar S. Giant lipoma over the back. Int Surg J 2022; 9(3): 687–689. doi: 10.18203/2349-2902.isj20220646.

9. Mello DF, Manica MZ, Junior AH. Giant lipomas: a 14-case series. Rev Bras Cir Plast 2015; 30(1): 33–37. doi: 10.5935/2177-1235.2015RBCP0113.

10. Ralli M, de Vincentiis M, Greco A. First, rule out cancer: giant lipoma. Am J Med 2018; 131(2): 146–147. doi: 10.1016/j.amjmed.2017.09.01.

11. Ko KM, Yang NR, Kim YG. Huge occipital spindle cell lipoma: a case report. J Korean Ster Func Neurosurg 2023; 19(1): 18–21. doi: 10.52662/jksfn.2023.00010.

12. Eryilmaz M, Yigit T, Ozturk G et al. Giant spindle cell lipoma of the posterior neck. Dermatol Surg 2007; 33(10): 1258–1261. doi: 10.1111/j.1524-4725.2007.33263.x.

13. Hrudka J, Hojný J, Večeřová M et al. Nízkotučná varianta vřetenobuněčného lipomu: kazuistika. Ces Slov Patol 2023; 59(4): 190–196.

14. Ohshima Y, Nishio J, Nakayama S et al. Spindle cell lipoma and pleomorphic lipoma: an update and review. Cancer Diagn Progn 2023; 3(3): 282–290. doi: 10.21873/cdp.10213.

15. Chen S, Huang H, He S et al. Spindle cell lipoma: clinicopathologic characterization of 40 cases. Int J Clin Exp Pathol 2019; 12(7): 2613–2621.

16. Thway K, Flora R, Shah C et al. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol 2012; 36(3): 462–469. doi: 10.1097/PAS.0b013e3182417330.

17. Clay MR, Martinez AP, Weiss SW et al. MDM2 amplification in problematic lipomatous tumors: analysis of FISH testing criteria. Am J Surg Pathol 2015; 39(10): 1433–1439. doi: 10.1097/PAS. 0000000000000468.